US$ 22.34
fda warning bpc-157 unapproved peptide safety risks new drug The FDA has issued clear signals on BPC-157: it is not approved for human use in any form due to potential significant risks. This critical Therapeutic Goods Administration issues safety
Description
Reported adverse reactions include paresthesia, somnolence, and decreased serum folic acid levels
Sore and swollen tongue
Fish tapeworm infestation
Vitamin B12 deficiency is diagnosed on the basis of blood tests